W. Jap

The anti-ischaemic activity of the novel compound, CERM 11956, compared with that of bepridil and nifedipine in isolated guinea-pig hearts.

B. Wilffert, E. Boddeke, P. V. van Zwieten, 1988, European journal of pharmacology.

New anti-ischaemic drugs: cytoprotective action with no primary haemodynamic effects.

E. Boddeke, P. V. van Zwieten, J. Hugtenburg, 1989, Trends in pharmacological sciences.

Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial.

H. Suryapranata, M. de Boer, J. Hoorntje, 2004, European heart journal.